Urolog. pro Praxi, 2009; 10(6): 339-340

One-day antibacterial prophylaxis for prostate biopsy

MUDr. Miloš Broďák Ph.D2, MUDr. Jaroslav Pacovský1, MUDr. Josef Košina2, MUDr. Lukáš Holub2, MUDr. Pavel Navrátil CSc2, MUDr. Miroslava Romžová2, MUDr. Miroslav Louda Ph.D2
1 Urologické klinika FN a LF UK Hradec Králové, Regionální transplantační centrum Hradec Králové
2 Urologická klinika FN a LF UK Hradec Králové

Transrectal prostate biopsy is basic procedure in the suspicion on the prostate cancer. The aim of the antibacterial prophylaxis is minimized

risk of infectious complications combined with this procedure. The authors present own experiences with oral quinolones given

as prophylaxis. According to our results it is proven that one-day antibacterial prophylaxis is efficient and safe in prostate biopsy.

Keywords: antibiotic prophylaxis, prostate biopsy, infectious complications.

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Broďák M, Pacovský J, Košina J, Holub L, Navrátil P, Romžová M, Louda M. One-day antibacterial prophylaxis for prostate biopsy. Urol. praxi. 2009;10(6):339-340.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Študent V, Grepl M, Král M, Hartmann I. Má vyšetření PSA stále význam při vyhledávání karcinomu prostaty? Urolog pro Praxi 2006; 5: 214-218.
    2. Klečka J, Holubec L, Pešta M, Hora M, Topolčan O, Eret V. Nádorové markery karcinomu prostaty. Ces Urol 2008; 12(3): 173-185.
    3. Matsumoto T, Kiyota H, Matsukawa M, Yasuda M, Arakawa S, Monden K. Japanese guidelines for prevention of perioperative infection in urological field. Int J Urol., 2007; 14: 890-909. Go to original source... Go to PubMed...
    4. Shigebara K, Miyagi T, Nakashima T, Shimamura M. Acute bacterial prostatitis after transrectal needle biopsy: clinical analysis. J Clin Chemother 2008; 14: 40-43. Go to original source...
    5. Zámečník L, Novák K, Šafařík L, Stolz J. Antibiotická profylaxe při transrektální biopsii prostaty. Urolog. pro Praxi 2003; 2: 46-48.
    6. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU International 2002; 89: 824-828. Go to original source... Go to PubMed...
    7. Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, Pertel PE. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int., 2007; 100: 51-57. Go to original source... Go to PubMed...
    8. Sabbagh R, McCormack M, Peloquin F, Faucher R, Perreault JP, Perrotte P, Karakiewics PI, Saad F. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol., 2004; 11: 2216-2219.
    9. European Association of Urology. Guidelines. Drukkerij Gelderland bv. Arnhem. 2009.
    10. Lugg J, Lettieri J, Stass H, Agarwal V. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1 000 mg, extended-release dose. J Chemother., 2008; 20: 213-218. Go to original source... Go to PubMed...
    11. Doležal T. Zanocin (Ofloxacin). Urolog pro Praxi 2003; 1: 37-38.
    12. Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral flouroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol., 1999; 31: 491-495. Go to original source... Go to PubMed...
    13. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graham E, Echols RM, Whalen E, Kowalsky SF. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology, 1998; 52: 552-558. Go to original source... Go to PubMed...
    14. Lindstedt S, Lindström U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol., 2006; 50: 832-837. Go to original source... Go to PubMed...
    15. Tobias-Machado M, Correa TD, De Baros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol., 2003; 29(4): 313-319. Go to original source... Go to PubMed...
    16. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol., 2002; 168(3): 1021-1023. Go to original source... Go to PubMed...
    17. Aron M, Rajeen TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int, 2000; 85: 492-494. Go to original source... Go to PubMed...
    18. Larsson P, Norming U, Törnblom M, Gustafsson O. Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer Prostatic Dis., 1999; 2: 88-90. Go to original source... Go to PubMed...
    19. Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate - risk factors and antibiotic prophylaxis. Br J Urol., 1996; 77(6): 851-855. Go to original source... Go to PubMed...
    20. Bootsma AM, Laguna Pes MP, Geerligs SE, Goosens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol., 2008; 54(6): 1270-1286. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.